Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC General

Displaying 1 to 10 of 81 Posts . Displaying 10 of Posts . Page of 9 . Go To Page: . Per Page: . . . View All Sort By: .

European Commission approves SKYRIZI® for psoriatic arthritis in adults

The European Commission has approved SKYRIZI® for the treatment of active psoriatic arthritis in adults.

Read More

Focus on Psoriasis – A Report from the 2021 Virtual EADV Congress

The European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical practice updates. You can download the full report or read a brief look at some of the highlights.

Read More

PsoProtect Registry Data Update

PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,272 cases.

Read More

Update on spesolimab for generalized pustular psoriasis

The European Medicines Agency (EMA) has accepted to review Boehringer Ingelheim’s marketing authorization application (MAA) for spesolimab to treat flares in generalised pustular psoriasis (GPP).

Read More

Focus on Psoriasis – A Report from the 2021 Virtual ESDR Congress

The ESDR congress included many noteworthy psoriasis presentations from both IPC councilors and experts from around the world. You can download the full report or read a brief look at some of the highlights.

Read More

World Psoriasis Day

IPC, along with the International Federation of Psoriasis Associations (IFPA), is UNITED with the 60 million people worldwide with psoriasis in celebrating October 29th annually as World Psoriasis Day. With the theme of UNITED this World Psoriasis Day, we remember that we can do so much more together than we can alone. Watch the video to hear IPC Councilors from around world explain what being united in psoriasis treatment means to them.

Read More

PsoProtect Registry Data Update

Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,205 cases.

Read More

July Update on PsoProtect Registry Data

Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,147 cases.

Read More

Expert Opinion: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based study

IPC Councilor, Luigi Naldi, MD, shares his expert opinion on a population-based study of COVID-19 - associated hospitalization and mortality in patients with psoriasis.

Read More

Grand Rounds tutorial on IPC's psoriasis severity reclassification

The AbbVie program features IPC Board Member Bruce Strober’s Grand Rounds, a tutorial explaining the current method of measuring the severity of psoriasis, why this limits proper care and treatment for psoriasis patients, how IPC’s Disease Severity Reclassification Project solves these problems, and how clinicians can implement this new classification method.

Read More

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

 

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK